Share
Market Research Report

THERAPEUTIC PLASMA EXCHANGE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By TypeCentrifugation (Intermittent and Continuous Flow Centrifugation) and Membrane Filtration
  • By Product TypeDevices · Consumables · and Software and Services
  • By Disease IndicationNeurological Disorders (Guillain–Barré syndrome, Chronic inflammatory demyelinating polyneuropathy(CIDP), Myasthenia gravis, Multiple sclerosis, Neuromyelitis optica) · Renal Disorders (Anti-GBM disease, Hematology Disorders, Metabolic Disorders, and Other Indications) · Hematology Disorders · Metabolic Disorders · and Others Indications
  • By Procedure TypeManual TPE · Automated TPE · and Double Filtered Plasmapheresis (DFPP)
  • By End UserHospitals · Specialty Clinics · Ambulatory Surgical Centers · Blood Collection Centers and Blood Component Providers · and Transfusion Centers
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In17 Mar 2026
  • Report CodeCMI8728
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2021 - 2033)

    • Centrifugation (Intermittent and Continuous Flow Centrifugation)
    • Membrane Filtration
  • Product Type Insights (Revenue, USD Bn, 2021 - 2033)

    • Devices
    • Consumables
    • Software and Services
  • Disease Indication Insights (Revenue, USD Bn, 2021 - 2033)

    • Neurological Disorders
      • Guillain–Barré syndrome
      • Chronic inflammatory demyelinating polyneuropathy (CIDP)
      • Myasthenia gravis
      • Multiple sclerosis
      • Neuromyelitis optica
    • Renal Disorders
      • Anti-GBM disease
      • Post-renal transplant rejection
      • Wegener’s granulomatosis
    • Hematology Disorders
      • Thrombotic thrombocytopenic purpura (TTP)
      • Hemolytic uremic syndrome (HUS)
      • Cryoglobulinemia
      • Multiple myeloma
    • Metabolic Disorders
      • Homozygous familial hypercholesterolemia
      • Fulminant Wilson’s disease
    • Other Indications
      • Autoimmune diseases (e.g., systemic lupus erythematosus)
      • Inflammatory disorders
  • Procedure Type Insights (Revenue, USD Bn, 2021 - 2033)

    • Manual TPE
    • Automated TPE
    • Double Filtered Plasmapheresis (DFPP)
  • End User Insights (Revenue, USD Bn, 2021 - 2033)

    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
    • Blood Collection Centers and Blood Component Providers
    • Transfusion Centers
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa